Tsang PS - Search Results

1

Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models.

Taylor JG 6th, Cheuk AT, Tsang PS, Chung JY, Song YK, Desai K, Yu Y, Chen QR, Shah K, Youngblood V, Fang J, Kim SY, Yeung C, Helman LJ, Mendoza A, Ngo V, Staudt LM, Wei JS, Khanna C, Catchpoole D, Qualman SJ, Hewitt SM, Merlino G, Chanock SJ, Khan J. Taylor JG 6th, et al. Among authors: tsang ps. J Clin Invest. 2009 Nov;119(11):3395-407. doi: 10.1172/JCI39703. Epub 2009 Oct 5. J Clin Invest. 2009. PMID: 19809159 Free PMC article.

2

Synthetic lethal screen identifies NF-κB as a target for combination therapy with topotecan for patients with neuroblastoma.

Tsang PS, Cheuk AT, Chen QR, Song YK, Badgett TC, Wei JS, Khan J. Tsang PS, et al. BMC Cancer. 2012 Mar 21;12:101. doi: 10.1186/1471-2407-12-101. BMC Cancer. 2012. PMID: 22436457 Free PMC article.

3

Systematic proteome analysis identifies transcription factor YY1 as a direct target of miR-34a.

Chen QR, Yu LR, Tsang P, Wei JS, Song YK, Cheuk A, Chung JY, Hewitt SM, Veenstra TD, Khan J. Chen QR, et al. J Proteome Res. 2011 Feb 4;10(2):479-87. doi: 10.1021/pr1006697. Epub 2010 Dec 23. J Proteome Res. 2011. PMID: 21182263 Free PMC article.

4

Screening a panel of drugs with diverse mechanisms of action yields potential therapeutic agents against neuroblastoma.

Gheeya JS, Chen QR, Benjamin CD, Cheuk AT, Tsang P, Chung JY, Metaferia BB, Badgett TC, Johansson P, Wei JS, Hewitt SM, Khan J. Gheeya JS, et al. Cancer Biol Ther. 2009 Dec;8(24):2386-95. doi: 10.4161/cbt.8.24.10184. Epub 2009 Dec 27. Cancer Biol Ther. 2009. PMID: 19946221 Free PMC article.

5

The MYCN oncogene is a direct target of miR-34a.

Wei JS, Song YK, Durinck S, Chen QR, Cheuk AT, Tsang P, Zhang Q, Thiele CJ, Slack A, Shohet J, Khan J. Wei JS, et al. Oncogene. 2008 Sep 4;27(39):5204-13. doi: 10.1038/onc.2008.154. Epub 2008 May 26. Oncogene. 2008. PMID: 18504438 Free PMC article.

6

TIMP-2 modulates VEGFR-2 phosphorylation and enhances phosphodiesterase activity in endothelial cells.

Lee SJ, Tsang PS, Diaz TM, Wei BY, Stetler-Stevenson WG. Lee SJ, et al. Among authors: tsang ps. Lab Invest. 2010 Mar;90(3):374-82. doi: 10.1038/labinvest.2009.136. Epub 2010 Jan 18. Lab Invest. 2010. PMID: 20084057 Free PMC article.

7

The brain microenvironment preferentially enhances the radioresistance of CD133(+) glioblastoma stem-like cells.

Jamal M, Rath BH, Tsang PS, Camphausen K, Tofilon PJ. Jamal M, et al. Among authors: tsang ps. Neoplasia. 2012 Feb;14(2):150-8. doi: 10.1593/neo.111794. Neoplasia. 2012. PMID: 22431923 Free PMC article.

8

MEPicides: potent antimalarial prodrugs targeting isoprenoid biosynthesis.

Edwards RL, Brothers RC, Wang X, Maron MI, Ziniel PD, Tsang PS, Kraft TE, Hruz PW, Williamson KC, Dowd CS, John ARO. Edwards RL, et al. Among authors: tsang ps. Sci Rep. 2017 Aug 21;7(1):8400. doi: 10.1038/s41598-017-07159-y. Sci Rep. 2017. PMID: 28827774 Free PMC article.

9

Preparation and Evaluation of Potent Pentafluorosulfanyl-Substituted Anti-Tuberculosis Compounds.

Moraski GC, Bristol R, Seeger N, Boshoff HI, Tsang PS, Miller MJ. Moraski GC, et al. Among authors: tsang ps. ChemMedChem. 2017 Jul 20;12(14):1108-1115. doi: 10.1002/cmdc.201700170. Epub 2017 Jun 27. ChemMedChem. 2017. PMID: 28654200 Free PMC article.

10

SAR and identification of 2-(quinolin-4-yloxy)acetamides as Mycobacterium tuberculosis cytochrome bc₁ inhibitors.

Phummarin N, Boshoff HI, Tsang PS, Dalton J, Wiles S, Barry Rd CE, Copp BR. Phummarin N, et al. Among authors: tsang ps. Medchemcomm. 2016 Nov 1;7(11):2122-2127. doi: 10.1039/c6md00236f. Epub 2016 Aug 22. Medchemcomm. 2016. PMID: 28337336 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31 results

Search Page